PBPH Holdings Information

PBPH is an equity ETF with a total of 56 individual holdings. The top holdings are Eli Lilly and Company stock at 16.17%, Johnson & Johnson at 9.69%, AbbVie at 7.00%, Merck & Co. at 4.98%, and Roche Holding AG at 4.52%.

Total Holdings

Top 10 Percentage

62.61%

Asset Class

Equity

ETF Category

Health

Assets

811.34M

PE Ratio

20.27

Breakdown by Country

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	16.17%	112,460
2	JNJ	Johnson & Johnson	9.69%	320,509
3	ABBV	AbbVie Inc.	7.00%	235,383
4	MRK	Merck & Co., Inc.	4.98%	328,970
5	SWX: ROP	Roche Holding AG	4.52%	92,324
6	SWX: NOVN	Novartis AG	4.43%	243,037
7	LON: AZN	AstraZeneca PLC	4.32%	194,981
8	AMGN	Amgen Inc.	4.31%	102,219
9	GILD	Gilead Sciences, Inc.	3.64%	246,222
10	CPH: NOVO.B	Novo Nordisk A/S	3.56%	632,652
11	PFE	Pfizer Inc.	3.22%	1,130,849
12	VRTX	Vertex Pharmaceuticals Incorporated	2.93%	50,247
13	BMY	Bristol-Myers Squibb Company	2.77%	405,041
14	LON: GSK	GSK plc	2.27%	739,162
15	EPA: SAN	Sanofi	2.17%	215,368
16	REGN	Regeneron Pharmaceuticals, Inc.	1.48%	20,048
17	EBR: ARGX	argenx SE	1.29%	12,276
18	ETR: BAYN	Bayer Aktiengesellschaft	1.20%	195,004
19	TYO: 4502	Takeda Pharmaceutical Company Limited	1.15%	307,151
20	ASX: CSL	CSL Limited	1.01%	109,224
21	ALNY	Alnylam Pharmaceuticals, Inc.	0.90%	26,349
22	TLV: TEVA	Teva Pharmaceutical Industries Limited	0.89%	229,746
23	SWX: SDZ	Sandoz Group AG	0.86%	81,053
24	NTRA	Natera, Inc.	0.85%	26,712
25	EBR: UCB	UCB SA	0.84%	23,737

Showing 25 of 56 holdings

Subscribe to see the full list

Activate Now

As of Jun 29, 2026